Deconstruction of non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 for exploration of the optimization landscape of fragments

scientific article published on 5 January 2011

Deconstruction of non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 for exploration of the optimization landscape of fragments is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/JM101052G
P698PubMed publication ID21207958

P50authorPeter BrandtQ57030030
P2093author name stringMatthis Geitmann
U Helena Danielson
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)709-718
P577publication date2011-01-05
P1433published inJournal of Medicinal ChemistryQ900316
P1476titleDeconstruction of non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 for exploration of the optimization landscape of fragments
P478volume54

Reverse relations

cites work (P2860)
Q27675974Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening
Q26826945Fragment screening and HIV therapeutics
Q38211688Harnessing allostery: a novel approach to drug discovery
Q35616254Ligand deconstruction: Why some fragment binding positions are conserved and others are not
Q49330155Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA.
Q41109181Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors.

Search more.